Joanne Wing Yan Chiu

Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial

Sara A. Hurvitz, Roberto Hegg, Wei‐Pang Chung et al. · The Lancet · 2022 · 642 citations · Full text

Medicine, Oncology, Pharmacology +16

Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors

Jeffrey Sum Lung Wong, Gerry Gin Wai Kwok, Vikki Tang et al. · Journal for ImmunoTherapy of Cancer · 2021 · 132 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

The use of single‐agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child‐Pugh B liver cirrhosis

Joanne Wing Yan Chiu, Yuen Fong Tang, Tzy‐Jyun Yao et al. · Cancer · 2012 · 69 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

The real-world use of regorafenib for metastatic colorectal cancer: multicentre analysis of treatment pattern and outcomes in Hong Kong

Ka-On Lam, Kin-Chung Lee, Joanne Wing Yan Chiu et al. · Postgraduate Medical Journal · 2016 · 23 citations

Medicine, Oncology, Pharmacotherapy +13

Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors.

Jeffrey Sum Lung Wong, Gin Wai Kwok, Vikki Tang et al. · Journal of Clinical Oncology · 2021 · 23 citations

Life Sciences, Oncology, Pharmacology +17